Adjustments for Non-Cash Items (USD)

Stock-Based Compensation (USD)

Changes in Working Capital (USD)

Capital Expenditures (CapEx) (USD)

Proceeds from / Repayments of Debt (USD)

Share Repurchases (USD)

Dividend Payments (USD)

Net Change in Cash (USD)

8b01d013d188daa1271d47d5000a2ae43f6e45e97fe4d12236fd7e1477513110

Total Revenue (USD)

Cost of Goods Sold (COGS) (USD)

Selling, General, and Administrative Expenses (SG&A) (USD)

Research and Development (R&D) (USD)

Depreciation and Amortization (D&A) (USD)

Interest Expense (USD)

Operating Income (EBIT) (USD)

Net Income (USD)

Earnings Per Share (EPS) - Basic (USD)

Earnings Per Share (EPS) - Diluted (USD)

e1e172b30136cdcc95767fd25b58a5f6b9b7567f8ad3b0619fcd1d71bb02856e

Current Assets (USD)

Cash and Cash Equivalents (USD)

Accounts Receivable (USD)

Inventory (USD)

Non-Current Assets (USD)

Property, Plant, and Equipment (PP&E) (USD)

Goodwill (USD)

Intangible Assets (USD)

Current Liabilities (USD)

Accounts Payable (USD)

Short-term Debt (USD)

Accrued Expenses (USD)

Non-Current Liabilities (USD)

Long-term Debt (USD)

Lease Liabilities (USD)

Deferred Tax Liabilities (USD)

Shareholders' Equity (USD)

Retained Earnings (USD)

Common Stock (USD)

Additional Paid-in Capital (USD)

4c4614e986de4b73a9093b6aeddf792a7776dda20914bd14958f5bca8a9f4412

Plasma Industry

Pharma Industry

- Pharma Prepaid

- Pharma Copay

Other

Total Revenue

09eda85d4342d410a8cc441ed471a6f66c6c633d2dd2f3d60d87c326b88130dd

Net income (USD)

Stock-based compensation expense (USD)

Depreciation and amortization (USD)

Noncash lease expense (USD)

Gain on disposal assets (USD)

Net cash provided by operating activities (USD)

Purchase of fixed assets (USD)

Capitalization of internally developed software (USD)

Purchase of intangible assets (USD)

Net cash used in investing activities (USD)

Proceeds from exercise of options (USD)

Repurchase of common stock (USD)

Net cash used in financing activities (USD)

Net change in cash and restricted cash (USD)

Cash paid for taxes (USD)

Deferred income taxes, net (USD)

Accounts receivable (USD)

Other receivables (USD)

Prepaid expenses and other current assets (USD)

Accounts payable and accrued liabilities (USD)

Operating lease liability (USD)

Customer card funding (USD)

Cash and restricted cash, beginning of period (USD)

Cash and restricted cash, end of period (USD)

Cash (USD)

Restricted cash (USD)

Total cash and restricted cash (USD)

1a65b93ae97dab27fed482d1486e4d325eb3cc9190ad5e5a136e2a712bd5bb5b

Total revenues (USD)

Cost of revenues (USD)

Gross profit (USD)

Selling, general and administrative expenses (USD)

Total operating expenses (USD)

Income (loss) from operations (USD)

Interest income, net (USD)

Income before income tax provision (benefit) (USD)

Income tax provision (benefit) (USD)

Net income (loss) (USD)

5df070b1462662cbd62f11458f759de4183ee71ef2b11c81625846250bc2c5cf

Restricted Cash (USD)

Accounts Receivable, Net (USD)

Other Receivables (USD)

Prepaid Expenses and Other Current Assets (USD)

Total Current Assets (USD)

Fixed Assets, Net (USD)

Intangible Assets, Net (USD)

Operating Lease Right-of-Use Asset (USD)

Deferred Tax Asset, Net (USD)

Total Assets (USD)

Accounts Payable and Accrued Liabilities (USD)

Operating Lease Liability, Current Portion (USD)

Customer Card Funding (USD)

Total Current Liabilities (USD)

Operating Lease Liability, Long-Term Portion (USD)

Total Liabilities (USD)

Treasury Stock at Cost (USD)

Total Stockholders' Equity (USD)

Total Liabilities and Stockholders' Equity (USD)

d5390766fabd2abc6fb454b9f2f4b88d2a49ec950c51f2ff133c91d1209c2091

Paysign Inc (PAYS)

Financials